Skovronsky Daniel
Myriad Genetics, Inc. · Director
Skovronsky Daniel is listed in public filings as director. This Skovronsky Daniel insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Myriad Genetics, Inc. (MYGN), and Eli Lilly and Co (LLY). Investors use Skovronsky Daniel's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --195.5k shares | Grant / ExerciseJun 4, 2026 | Disclosure amount unavailable59.7k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $167M160.1k shares | Grant / ExerciseFeb 9, 2026 | $16.2M15.5k shares | $1,044.67 | -- | |
| $150M144.5k shares | Grant / ExerciseFeb 1, 2026 | $5.9M5.6k shares | $1,037.15 | -- | |
| --12.7k shares | Grant / ExerciseFeb 1, 2026 | Disclosure amount unavailable12.7k shares | -- | -- | |
| --137.5k shares | Grant / ExerciseNov 10, 2025 | Disclosure amount unavailable179 shares | -- | -- | |
| --135.8k shares | Grant / ExerciseJun 5, 2025 | Disclosure amount unavailable49.8k shares | -- | -- |